Hajak_edit.qxp 1/7/08 10:53 Page 39
Chronic Insomnia
1. American Psychiatric Association, Diagnostic and Statistical aspects of primary insomnia: implications for its treatment, professional impact of insomnia, Sleep, 2002;25:625–9.
Manual of Mental Disorders, 4th Ed, Text Revision (DSM-IV-TR), Sleep Med Rev, 2006;10:255–66. 56. Hatoum HT, Kong SX, Kania CM, et al., Insomnia, health-
Washington DC: American Psychiatric Association, 2000. 28. Vgontzas AN, Tsigos C, Bixler EO, et al., Chronic insomnia related quality of life and healthcare resource consumption. A
2. American Academy of Sleep Medicine, The International and activity of the stress system: a preliminary study, study of managed-care organisation enrollees,
Classification of Sleep Disorders, second edition. Diagnostic and J Psychosom Res, 1998;45:21–31. Pharmacoeconomics, 1998;14:629–37.
Coding Manual, Westchester: American Academy of Sleep 29. Bonnet MH, Arand DL, 24-hour metabolic rate in insomniacs 57. Martin SA, Aikens JE, Chervin RD, Toward cost-effectiveness
Medicine, 2005. and matched normal sleepers, Sleep, 1995;18:581–8. analysis in the diagnosis and treatment of insomnia, Sleep
3. World Health Organization, Tenth revision of the international 31. Lushington K, Dawson D, Lack L, Core body temperature is Med Rev, 2004;8:63–72.
classification of diseases, chapter V (F): Mental and Behavioural elevated during constant wakefulness in elderly poor sleepers, 58. Ozminkowski RJ, Wang S, Walsh JK, The direct and indirect
Disorders (including disorders of psychological development) Sleep, 2000;23:504–10. costs of untreated insomnia in adults in the United States,
Clinical descriptions and guidelines, Geneva: World Health 32. Buckley TM, Schatzberg AF, On the interactions of the Sleep, 2007;30:263–73.
Organization, 1991. hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal 59. Ohayon MM, Caulet M, Guilleminault C, How a general
4. Ohayon M, Epidemiology of insomnia: What we know and HPA axis activity and circadian rhythm, exemplary sleep population perceives its sleep and how this relates to the
what we still need to learn, Sleep Med Rev, 2002;6(2): disorders, J Clin Endocrinol Metab, 2005;90:3106–14. complaint of insomnia, Sleep, 1997;20(9):715–23.
97–111. 32. Richardson GS, Roth T, Future directions in the management 60. Rayon P, Serrano-Castro M, del Barrio H, et al., Hypnotic drug
5. Üstün T, Sartorius N, Mental illness in general health care: an of insomnia, J Clin Psychiatry, 2001;62(Suppl. 10):39–45. use in Spain: a cross-sectional study based on a network of
international study, London: John Wiley & Sons, 1995. 33. Basta M, Chrousos GP, Vela-Bueno A, Vgontzas AN, Chronic community pharmacies. Spanish Group for the Study of
6. Üstün T, Privett M, LeCrubier Y, et al., Form, frequency, and insomnia and stress system, Sleep Med Clin, 2008;2(2): Hypnotic Drug Utilization, Ann Pharmacother, 1996;30(10):
burden of sleep problems in general health care, Eur J 279–91. 1092–1100.
Psychiatry, 1996;11(Suppl. 1):5S–10S. 34. Riemann D, Voderholzer U, Spiegelhalder K, et al., Chronic 61. Eisenberg L, Treating anxiety and depression in primary care:
7. Roth T, Prevalence, associated risks, and treatment patterns insomnia and MRI-measured hippocampal volumes: a pilot closing the gap between knowledge and practice, N Engl J
of insomnia, J Clin Psychiatry, 2005;66:10–13. study, Sleep, 2007;30:955–8. Med, 1992;326:1080–84.
8. Ancoli-Israel S, Manifestiations and management of chronic 35. Backhaus J, Junghanns K, Born J, et al., Impaired declarative 62. Simon GE, Can depression be managed appropriately in
insomnia. Summary of the NIH consensus statement, Insom, memory consolidation during sleep in patients with primary primary care?, J Clin Psychiatry, 1998;59(Suppl. 2):3–8.
2007;9:18–25. insomnia: influence of sleep architecture and nocturnal 63. Roth T, Hajak G, Üstün B, Consensus for the pharmacologic
9. National Institutes of Health, National Institutes of Health cortisol release, Biol Psychiatry, 2006;60:1324–30. management of insomnia in the new millenium, Int J Clin
State of the Science Conference statement on Manifestations 36. Nissen C, Klöpfer C, Nofzinger EA, et al., Impaired sleep- Pract, 2001;55:1–11.
and Management of Chronic Insomnia in Adults (June 13–15, related memory consolidation in primary insomnia, Sleep, 64. Morin AK, Strategies for treating chronic insomnia, Am J
2005), Sleep, 2005;28:1049–57. 2006;29:1068–73. Manag Care, 2006;12(Suppl. 8):230–45.
10. Edinger JD, Bonnet MH, Bootzin RR, et al. American Academy 37. Hajak G, Popp R, Are sleep disorders a cause or a 65. Morin CM, Bootzin RR, Buysse DJ, et al., Psychological and
of Sleep Medicine Work Group, Derivation of research consequence of depression?, Medicographia, 2007;29(1): behavioral treatment of insomnia: Update of the recent
diagnostic criteria for insomnia: report of an American 66–7. evidence (1998–2004), Sleep, 2006;29:1398–1414.
Academy of Sleep Medicine Work Group, Sleep, 2004;27: 38. Taylor DJ, Lichstein KL, Durrence HH, et al., Epidemiology of 66. Bhat A, Shafi F, El Solh AA, Pharmacotherapy of insomnia,
1567–96. insomnia, depression, and anxiety, Sleep, 2005;28(11): Expert Opin Pharmacother, 2008;9(3):351–62.
11. Krystal AD, The changing perspective on chronic insomnia 1457–64. 67. Ebert B, Wafford KA, Deacon S, Treating insomnia: Current
management, J Clin Psychiatry, 2004;65(Suppl. 8):20–25. 39. Roth T, Insomnia: Definition, prevalence, etiology, and and investigational pharmacological approaches, Pharmacol
12. Roth T, Franklin M, Bramley TJ, The state of insomnia and consequences, J Clin Sleep Med, 2007;3(Suppl. 5):7–10. Ther, 2006;112:612–29.
emerging trends, Am J Manag Care, 2007;13:S117–S120. 40-. Reimer MA, Flemons WW, Quality of life in sleep disorders, 68. Morin AK, Jarvis CI, Lynch AM, Therapeutic Options for Sleep-
13. Summers MO, Crisostomo MI, Stepanski EJ, Recent Sleep Med Rev, 2003;7:335–49. Maintenance and Sleep-Onset Insomnia, Pharmacotherapy,
developments in the classification evaluation, and treatment 41. Katz DA, McHorney CA, Clinical correlates of insomnia in 2007;27(1):89–110.
of insomnia, Chest, 2006;130:276–86. patients with chronic illness, Arch Intern Med, 1998;158: 69. Szabadi E, Drugs for sleep disorders: mechanisms and
14. Doghramji K, The epidemiology and diagnosis of insomnia, 1099–1107. therapeutic prospects, Br J Clin Pharmacol, 2006;61(6):
Am J Manag Care, 2006;12(Suppl. 8):214–20. 42. Katz DA, McHorney CA, The relationship between insomnia 761–6.
15. Ancoli-Israel S, The impact and prevalence of chronic and health-related quality of life in patients with chronic 70. Roth T, Understanding neuronal pathways: Novel targets for
insomnia and other sleep disturbances associated with chronic illness, J Fam Pract, 2002;51:229–35. the management of insomnia, J Clin Psychiatry,
illness, Am J Manag Care, 2006;12(Suppl. 8):221–9. 43. Riemann D, Voderholzer U, Primary insomnia: a risk factor to 2007;68(Suppl. 5):4–5.
16. Chevalier H, Los F, Boichut M, et al., Evaluation of severe develop depression?, J Affect Disord, 2003;76:255–9. 71. Perlis M, Spiegelhalder K, Voderholzer U, et al.,
insomnia in the general population of a European 44. Schwartz S, McDowell AW, Cole SR, et al., Insomnia and Pharmakotherapie der Insomnie, State of the Art, Somnologie,
multinational survey, J Psychopharmacol, 1999;13(Suppl. 4): heart disease: a review of epidemiologic studies, J Psychosom 2007;11:74–81.
21–4. Res, 1999;47:313–33. 72. Tariq SH, Pulisetty S, Pharmacotherapy for insomnia, Clin
17. Hajak G; SINE study group, Epidemiology of severe insomnia 45. Suka M, Yoshida K, Sugimori H, Persistent insomnia is a Geriatr Med, 2008;24:93–105.
and its consequences in Germany, Eur Arch Psychiatry Clin predictor of hypertension in Japanese male workers, J Occup 73. Lieberman JA, Update on the safety considerations in the
Neurosci, 2001;251:49–56. Health, 2003;45:344–50. management of insomnia with hypnotics: incorporating
18. Fullerton DS, The economic impact of insomnia in managed 46. Althuis MD, Fredman L, Langenberg PW, Magaziner J, The modified-release formulations into primary care, Prim Care
care: a clearer picture emerges, Am J Manag Care, relationship between insomnia and mortality among Companion J Clin Psychiatry, 2007;9(1):25–31.
2006;12(Suppl. 8):S246–52. community-dwelling older women, J Am Geriatr Soc, 1998;46: 74. Hajak G, Therapeutics of insomnia. New paradigms in
19. Stepanski EJ, Rybarczyk B, Emerging research on the 1270–73. pharmacological treatment of insomnia, Sleep Med,
treatment and entiology of secondary or comorbid insomnia, 47. Janson C, Lindberg E, Gislason T, et al., Insomnia in men: a 2006;7(Suppl. 1):S20–S36.
Sleep Med Rev, 2006;10:7–18. 10-year prospective population based study, Sleep, 75. Krystal AD, Walsh JK, Laska E, et al., Sustained efficacy of
20. Taylor DJ, Mallory LJ, Lichstein KL, et al., Comorbidity of 2001;24:425–30. eszopiclone over 6 months of nightly treatment: results of a
chronic insomnia with medical problems, Sleep, 2007;30(2): 48. Kripke DF, Garfinkel I, Wingard DL, Mortality associated with randomized, double-blind, placebo-controlled study in adults
213–18. sleep duration and insomnia, Arch Gen Psychiatry, 2002;59: with chronic insomnia, Sleep, 2003;26:793–9.
21. Hajak G, Insomnia in primary care, Sleep, 2000;23(Suppl. 3): 131–6. 76. Walsh JK, Krystal AD, Amato DA, et al., Nightly treatment of
54–63. 49. Pollak CP, Perlick D, Linsner JP, et al., Sleep problems in primary insomnia with eszopiclone for six months: effect on
22. Breslau N, Roth T, Rosenthal L, Andreski P, Sleep disturbance community elderly as predictors of death and nursing home sleep, quality of life, and work limitations, Sleep, 2007;30(8):
and psychiatric disorders: A longitudinal epidemiological study placement, J Community Health, 1990;15:123–35. 959–68.
of young adults, Biol Psychiatry, 1996;39:411–18. 50. Burgos I, Richter L, Klein T, et al., Increased nocturnal 77. Krystal AD, Erman M, Zammit GK, et al.; ZOLONG Study
23. Nowell PD, Buysse DJ, Reynolds CF III, et al., Clinical factors Interleukin-6 excretion in patients with primary insomnia: a Group, Long-term efficacy and safety of zolpidem extended-
contributing to the differential diagnosis of primary insomnia pilot study, Brain Behav Immun, 2006;20:246–53. release 12,5 mg, administered 3 to 7 nights per week for 24
and insomnia related to mental disorders, Am J Psychiatry, 51. Mander B, Colecchia E, Spiegel K, et al., Short sleep: A risk weeks, in patients with chronic primary insomnia: A 6-month,
1997;154(10):1412–16. factor for insulin resistance and obesity, Diabetes, 2001;50: randomized, double-blind, placebo-controlled, parallel-group,
24. Roth T, Roehrs T, Pies R, Insomnia: pathophysiology and A45. multicenter study, Sleep, 2008;31:79–90.
implications for treatment, Sleep Med Rev, 2007;11:71–9. 52. Metlaine A, Leger D, Choudat D, Socioeconomic impact of 78. Pollack M, Kinrys G, Krystal A, et al., Eszopiclone
25. Nofzinger EA, Buysse D, Germain A, et al., Functional insomnia in working populations, Ind Health, 2005;43:11–19. coadministered with escitalopram in patients with insomnia
neuroimaging evidence for hyperarousal in insomnia, Am J 53. Zammit GK, Weiner J, Damato N, et al., Quality of life in and comorbid generalized anxiety disorder, Arch Gen
Psychiatry, 2004;161:2126–8. people with insomnia, Sleep, 1999;22(Suppl. 2):379–85. Psychiatry, 2008;65(5):551–62.
26. Perlis ML, Smith MT, Andrews PJ, et al., Beta/gamma EEG 54. Kuppermann M, Lubeck DP, Mazanson PD, et al., Sleep 79. Krystal A, Fava M, Rubens R, et al., Evaluation of eszopiclone
activity in patients with primary and secondary insomnia and problems and their correlates in a working population, discontinuation after cotherapy with fluoxetine for insomnia
good sleeper controls, Sleep, 2001;24:110–17. J Gen Intern Med, 1995;10:25–32. with coexisting depression, J Clin Sleep Med, 2007;3(1):
27. Cortoos A, Verstraeten E, Cluydts R, Neurophysiological 55. Léger D, Guilleminault C, Bader G, et al., Medical and socio- 48–55.
EUROPEAN PSYCHIATRIC REVIEW 39
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76